New epilepsy drug study targets seniors
NCT ID NCT07422233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested the drug levetiracetam in 137 elderly patients (age 60+) with epilepsy. Researchers measured how many stayed seizure-free, how long until the next seizure, and how well patients tolerated the medication. The goal was to see if this drug is effective and safe for older adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mazandaran University of medical sciences
Sari, Mazandaran, 4815733971, Iran
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?
- Can invisible electric fields quiet the Brain's seizure signals?